Miltefosine - CAS 58066-85-6

Miltefosine (HePC) is the treatment of visceral and cutaneous leishmaniasis drug , and is proceeding clinical trials for this in several countries. Several medical agents produce some potency against visceral or cutaneous leishmaniasis, however a 2005 survey concluded that miltefosine is the only effective oral treatment for both forms of leishmaniasis.

Parasite, HIV Protease, Akt, PKC

PI3K/Akt/mTOR signaling, Cytoskeletal Signaling, Microbiology/Virology, Proteases/Proteasome, Chromatin/Epigenetic

57975

0.9994

C21H46NO4P

407.57

O(P(OCC[N+](C)(C)C)(=O)[O-])CCCCCCCCCCCCCCCC

-20°C

Ice Packs

Small Compound